Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norman Therribout

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Frontiers in Psychiatry|July 15, 2022
Feasibility of an Extensive Strategy for Adult Diagnosis of Attention Deficit Hyperactivity Disorder Among Patients Suffering From Substance Use DisordersNorman Therribout, Emily Karsinti, Alix Morel, et al.
Frontiers in Psychiatry|December 19, 2022
A specific cognitive behavioral group therapy program for stimulant use disorderEmily Karsinti, Florence Vorspan, Norman Therribout, et al.
International Journal of Clinical and Health Psychology : IJCHP|April 24, 2026
Psychometric properties of ADHD screening and diagnostic tools in patients with severe substance use disordersNorman Therribout, Lucia Romo, Thibault Hennequin, et al.
The Journal of Clinical Psychiatry|December 26, 2024
Treatments and Treatment Predictors in Patients With Substance Use Disorders and Comorbid Attention-Deficit/Hyperactivity Disorder: First Results From the International Naturalistic Cohort Study of ADHD and SUD (INCAS)Christoffer Brynte, Arnt Schellekens, Csaba Barta, et al.
BMC Psychiatry|September 23, 2022
The clinical course of comorbid substance use disorder and attention deficit/hyperactivity disorder: protocol and clinical characteristics of the INCAS studyChristoffer Brynte, Myriam Aeschlimann, Csaba Barta, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Frontiers in Psychiatry|July 15, 2022
Feasibility of an Extensive Strategy for Adult Diagnosis of Attention Deficit Hyperactivity Disorder Among Patients Suffering From Substance Use DisordersNorman Therribout, Emily Karsinti, Alix Morel, et al.
Frontiers in Psychiatry|December 19, 2022
A specific cognitive behavioral group therapy program for stimulant use disorderEmily Karsinti, Florence Vorspan, Norman Therribout, et al.
International Journal of Clinical and Health Psychology : IJCHP|April 24, 2026
Psychometric properties of ADHD screening and diagnostic tools in patients with severe substance use disordersNorman Therribout, Lucia Romo, Thibault Hennequin, et al.
The Journal of Clinical Psychiatry|December 26, 2024
Treatments and Treatment Predictors in Patients With Substance Use Disorders and Comorbid Attention-Deficit/Hyperactivity Disorder: First Results From the International Naturalistic Cohort Study of ADHD and SUD (INCAS)Christoffer Brynte, Arnt Schellekens, Csaba Barta, et al.
BMC Psychiatry|September 23, 2022
The clinical course of comorbid substance use disorder and attention deficit/hyperactivity disorder: protocol and clinical characteristics of the INCAS studyChristoffer Brynte, Myriam Aeschlimann, Csaba Barta, et al.
Pageof 1